Search Results - "Polizzi, Donatella"
-
1
BBR 3464: A Novel Triplatinum Complex, Exhibiting a Preclinical Profile of Antitumor Efficacy Different from Cisplatin
Published in Clinical cancer research (01-07-2000)“…Multinuclear platinum complexes represent a new class of anticancer agents, distinct in terms of DNA binding features and the profile of antitumor activity…”
Get full text
Journal Article -
2
Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines
Published in Current medicinal chemistry (01-01-2001)“…Cellular resistance to anthracyclines is a major limitation of their clinical use in the treatment of human tumors. Resistance to doxorubicin is described as a…”
Get more information
Journal Article -
3
Oral Efficacy and Bioavailability of a Novel Taxane
Published in Clinical cancer research (01-05-2000)“…A novel taxane (IDN 5109), originally selected for its ability to overcome P-glycoprotein-mediated drug resistance, is characterized by an improved preclinical…”
Get full text
Journal Article -
4
Molecular mechanisms of resistance to taxanes and therapeutic implications
Published in Drug resistance updates (01-12-1999)“…The mechanism of resistance to taxanes has not been fully elucidated. Since Taxol is a substrate for P-glycoprotein, overexpression of this transport system is…”
Get full text
Journal Article -
5
Growth‐inhibitory effects of luteinizing hormone‐releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen‐independent prostate cancer cell line in nude mice
Published in International journal of cancer (18-05-1998)“…Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone‐unresponsive prostate cancer in vivo. Male nude mice were…”
Get full text
Journal Article -
6
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts
Published in Oncology (01-01-2001)“…Systematic investigation of a novel series of intercalating agents, 9-aza-anthrapyrazoles, has led to the identification of a promising analogue, BBR 3438…”
Get more information
Journal Article -
7
Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic
Published in Current medicinal chemistry (01-01-2001)“…Multidrug resistance may be conferred by P-glycoprotein (Pgp, ABCB1) or the multidrug resistance associated protein (MRP). These membrane proteins are members…”
Get more information
Journal Article -
8
A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes
Published in International journal of cancer (01-06-2001)“…Loss of p53 function has been linked to increased responsiveness to taxane treatment of ovarian carcinoma in clinical studies. We recently reported that the…”
Get full text
Journal Article -
9
A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts
Published in Cancer research (Chicago, Ill.) (01-03-1999)“…Clinically available taxanes represent one of the most promising class of antitumor agents, despite several problems with their solubility and toxicity. In an…”
Get full text
Journal Article -
10
Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin
Published in Biochemical pharmacology (15-06-2000)“…Targeting of deregulated protein tyrosine kinases has been proposed as a new approach in the therapeutic intervention against pathological processes including…”
Get full text
Journal Article -
11
Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145 prostate cancer cells
Published in The Prostate (01-03-2001)“…BACKGROUND RORα is a transcription factor which belongs to the family of orphan nuclear receptors. The regulatory functions of this receptor are still poorly…”
Get full text
Journal Article -
12
Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs
Published in Biochemical pharmacology (01-07-2000)“…A variety of cytotoxic agents effective as antitumor drugs are known to kill tumor cells through induction of apoptosis as the most relevant modality of cell…”
Get full text
Journal Article -
13
Doxorubicin disaccharide analogue : Apoptosis-related improvement of efficacy in vivo
Published in JNCI : Journal of the National Cancer Institute (20-08-1997)“…Although doxorubicin remains one of the most effective agents for the treatment of solid tumors, there is an intensive effort to synthesize doxorubicin…”
Get full text
Journal Article -
14
Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts
Published in Clinical cancer research (01-11-1998)“…On the basis of a structure-activity study of a new series of anthracycline disaccharides, we recently identified a doxorubicin analogue (MEN 10755) with a…”
Get full text
Journal Article -
15
Activation of the orphan nuclear receptor ROR? induces growth arrest in androgen-independent DU 145 prostate cancer cells
Published in The Prostate (01-03-2001)Get full text
Journal Article -
16
Doxorubicin Disaccharide Analogue: Apoptosis-Related Improvement of Efficacy In Vivo
Published in Journal of the National Cancer Institute (20-08-1997)“…Background: Although doxorubicin remains one of the most effective agents for the treatment of solid tumors, there is an intensive effort to synthesize…”
Get full text
Report